Evvy
Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.
$40MSeries B
ParticipantRI
Rethink Impact
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rethink Impact is the investment firm named by Nectir and Evvy.
Recorded funding activity
Nectir provides infrastructure for higher-education AI. Evvy combines microbiome testing with clinician review and optional care. The firm remains distinct from Rethink Ventures and retains company-specific financing roles.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $40M 1 disclosed · full round size, not this investor’s share